2nd Circ. Backs Lilly Win In Drug Label Warning MDL
The Second Circuit upheld a victory for Eli Lilly & Co. on Tuesday in a suit in multidistrict litigation claiming it failed to warn of diabetes risks linked to an antipsychotic...To view the full article, register now.
Already a subscriber? Click here to view full article